Iovance Biotherapeutics
IOVA
$10.80
Share price
-19.75%
Change (1 day)
46.67%
Change (1 year)
Categories
Iovance Biotherapeutics (IOVA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.78 B
According to Iovance Biotherapeutics 's latest financial reports the company's total assets are $0.78 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Iovance Biotherapeutics - Total assets on balance sheet (from 2008 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.78 B | 17.53% |
| 2022-12-31 | $0.66 B | -14.58% |
| 2021-12-31 | $0.77 B | 1.15% |
| 2020-12-31 | $0.76 B | 122.96% |
| 2019-12-31 | $0.34 B | -28.32% |
| 2018-12-31 | $0.48 B | 209.46% |
| 2017-12-31 | $0.15 B | -9.61% |
| 2016-12-31 | $0.17 B | 62.69% |
| 2015-12-31 | $0.10 B | 127.18% |
| 2014-12-31 | $46.5 M | 134.01% |
| 2013-12-31 | $19.87 M | 67467.57% |
| 2012-12-31 | $0.02 M | -94.83% |
| 2011-12-31 | $0.56 M | -61.09% |
| 2010-12-31 | $1.46 M | 15067.69% |
| 2009-12-31 | $0 M | 71.63% |
| 2008-12-31 | $0 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.27 M | -99.97% | Bahamas |
 NRC Health
NRC | $0.12 B | -84.31% | 🇺🇸 USA |